December 09, 2024 Johnson & Johnson Seeks First Drug Approval for Treatment of Smoldering Myeloma Read the Full Article
June 04, 2024 Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma Read the Full Article
